How Is the US Cell Therapy Market Driving Innovation in Advanced Therapies?
The US Cell Therapy Market is at the forefront of the global shift toward advanced‑therapies, where living cells—rather than small‑molecule‑drugs or antibodies—are used to treat or cure severe diseases. The United States hosts a large share of clinical‑trials, FDA‑approvals, and commercial‑infrastructure for cell‑based treatments, including CAR‑T, stem‑cell therapies, and...
0 Kommentare 0 Geteilt 145 Ansichten 0 Bewertungen